Compounded Hair Loss Support: Custom Topical Options Explained
Some hair loss treatments are available over the counter. Others exist only as compounded preparations because no manufacturer makes them at the strength or in the combination a prescriber wants. Here is what separates the two, and what a patient should know before starting either.
What compounded hair loss support means
Compounded hair loss support means a scalp preparation made individually by a pharmacy to a prescriber's exact specification. It exists because manufactured products come in fixed strengths and single ingredients, and a prescriber sometimes wants something else.
Most compounded hair preparations are liquids, foams or gels applied directly to the scalp. Some combine two or more actives so a patient applies one product instead of layering several.
A compounded preparation requires a valid prescription. It is not something a patient can request directly from a pharmacy.
What already has FDA approval
Topical minoxidil is FDA approved and available over the counter, and oral finasteride is FDA approved for male pattern hair loss. If an approved product fits the patient, that is usually the sensible place to start.
Topical minoxidil is sold at 2 percent and 5 percent without a prescription. Oral finasteride is approved for men only. It is not approved for women.
Compounding becomes relevant when a prescriber wants a higher minoxidil strength, a combination product, a topical version of an oral drug, or a formulation without an ingredient the patient reacts to.
A compounded preparation is not an upgraded version of an approved product. It is a different thing, made for a specific reason. Approved products have been through testing that compounded preparations have not.
The agents prescribers use
Prescribers select from several agents that work through different mechanisms, and the evidence behind each one differs considerably. The table below shows where each stands.
| Agent | How it works | FDA approved product for hair loss | Topical evidence |
|---|---|---|---|
| Minoxidil | A vasodilator that acts on the hair follicle | Yes. Topical 2 percent and 5 percent over the counter. | Well established at approved strengths |
| Finasteride | Reduces conversion of testosterone to DHT | Oral only, for men. No approved topical product. | Studied, results mixed across trials |
| Dutasteride | Reduces DHT through a broader enzyme block | No approved product for hair loss | Limited |
| Spironolactone | Blocks androgen effects at the receptor | No approved product for hair loss | Limited for topical use |
Mixwell compounds to the prescription received. The pharmacy does not select the agents, the strengths or the patient.
Safety information you need before starting
Two of the agents used in hair loss compounding carry pregnancy exposure risks that apply to handling the product, not only to taking it. Read this section before starting any preparation containing finasteride, dutasteride or spironolactone.
Finasteride and dutasteride can affect the development of a male fetus. Women who are pregnant or who may become pregnant should not handle these preparations. Spironolactone is an antiandrogen and carries its own pregnancy cautions. Prescribers counsel patients on exposure precautions, including precautions relating to partners who are pregnant or may become pregnant. Follow the directions on your prescription label and ask your prescriber if anything is unclear.
Other effects worth knowing
Topical minoxidil commonly causes scalp irritation or dryness. Some patients react to propylene glycol in the vehicle rather than to the minoxidil itself. Unwanted hair growth on the face can occur, and it is reported more often in women.
Finasteride can be absorbed into the bloodstream even when applied topically. Sexual and mood related adverse effects have been reported with finasteride. Prescribers assess suitability and monitor accordingly.
What the evidence says
Evidence for combination topical therapy is promising but not settled. A 2025 systematic review and meta analysis of seven randomized controlled trials reported greater improvement in hair density and diameter with a topical minoxidil and finasteride combination than with minoxidil alone, while noting heterogeneity, small sample sizes and the need for larger confirmatory trials.
Individual trials have not all agreed. A separate 2025 randomized controlled trial found improvement from baseline in both the combination group and the minoxidil alone group, with no statistically significant difference between them.
Evidence for topical dutasteride and topical spironolactone is more limited than for minoxidil or finasteride. No compounded hair preparation is a proven treatment, and none is FDA approved.
What compounding adds and what it does not
Compounding provides strengths, combinations and vehicles that manufactured products do not offer. It does not make a preparation safer, stronger acting or more effective than an approved product.
What compounding can do
- Prepare minoxidil above the strengths sold over the counter
- Combine two or more actives into one scalp application
- Provide a topical version of a drug sold only as an oral tablet
- Leave out propylene glycol or another ingredient a patient reacts to
What it does not mean
- That the preparation is safer than an approved product
- That it is more effective than an approved product
- That it has been tested the way an approved product is tested
- That results are promised or predictable for any individual
Have a question about strengths, combinations or vehicle selection for a scalp preparation?
Call (909) 378-7301Questions worth asking your prescriber
Bring these to the visit before starting a compounded scalp preparation. They cover the points patients most often find out about later.
Is an over the counter or FDA approved option reasonable for me first? What does each ingredient in this preparation do? Are there handling precautions if someone in my household is pregnant or may become pregnant? How long before we reassess, and what would make us stop?
- Pharmacy
- Mixwell Compounding Pharmacy
- Address
- 13788 Roswell Ave, Ste 158, Chino, CA 91710
- Phone
- (909) 378-7301
- Fax
- (909) 378-7071
- info@mixwellpharmacy.com
Sending a prescription to Mixwell
Note the actives, strengths, vehicle, quantity and directions on a patient specific prescription, then fax or e prescribe it to the Chino pharmacy. Call first if you want to discuss vehicle selection for a multi active scalp preparation.
- Specify each active with its strength, plus the vehicle and total volume.
- Fax or e prescribe to Mixwell Compounding Pharmacy in Chino, CA.
- Call (909) 378-7301 to confirm the formulation or check current turnaround time.
- The patient can pick up in Chino, or the pharmacy can deliver.
Serving prescribers and patients in California
Mixwell Compounding Pharmacy is located in Chino, CA and works with dermatology and primary care prescribers across the Inland Empire, Los Angeles County and Orange County. Patients can collect their preparation at the Chino pharmacy, and delivery is available across California.
- Chino
- Chino Hills
- Ontario
- Rancho Cucamonga
- Upland
- Pomona
- Diamond Bar
- Corona
- Riverside
- Eastvale
- Brea
- Fullerton
Common questions
Do I need a prescription for compounded hair loss treatment?
Yes. Compounded preparations are made individually under a valid prescription from a licensed prescriber. Topical minoxidil at 2 percent and 5 percent is available over the counter without a prescription, but compounded preparations are not.
Is compounded minoxidil stronger than what I can buy?
A prescriber can specify a strength above the 2 percent and 5 percent sold over the counter. A higher strength is not automatically better or safer, and side effects such as scalp irritation can increase. The prescriber decides what is appropriate.
Can women use topical finasteride for hair loss?
Finasteride is not FDA approved for women, and it can affect the development of a male fetus. Women who are pregnant or who may become pregnant should not handle finasteride preparations. Any use in women is a decision made by the prescriber after individual assessment.
Are compounded hair loss preparations FDA approved?
No. Compounded preparations are not FDA approved. They are prepared individually under a prescription. FDA approved options for hair loss do exist, including topical minoxidil and oral finasteride for men.
How long before I know whether it is working?
Hair growth changes slowly, and prescribers generally reassess after a period of consistent use rather than after a few weeks. Ask your prescriber what timeline they expect and what would prompt a change.
Should I talk to my provider before starting?
Yes. FDA recommends that patients talk with their health care professional about their specific circumstances before taking any medication, including compounded preparations.
Does Mixwell accept insurance?
Mixwell does not accept insurance. Call (909) 378-7301 to discuss current pricing.
Key Takeaways
- Topical minoxidil at 2 percent and 5 percent is FDA approved and sold over the counter, and oral finasteride is FDA approved for men.
- Compounded scalp preparations exist to provide strengths, combinations or vehicles that no manufacturer makes, not to improve on approved products.
- Finasteride and dutasteride can affect the development of a male fetus, so women who are pregnant or may become pregnant should not handle these preparations.
- Evidence for combination topical therapy is promising but mixed across trials, and no compounded hair preparation is a proven or approved treatment.
- Compounded preparations are not FDA approved and require a valid prescription from a licensed prescriber.
Sources
- Zhang Y, Zhou Z, et al. Comparing minoxidil finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta analysis of randomized controlled trials. Frontiers in Medicine. 2025.
- Lubis FF, Legiawati L, Saulina M, Saldi SRF. Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1 percent finasteride and 5 percent minoxidil in male androgenetic alopecia. Archives of Dermatological Research. 2025;317(1):691. Trial registration NCT05990400.
- U.S. Food and Drug Administration. Finasteride prescribing information, including pregnancy and handling precautions.
- U.S. Food and Drug Administration. Minoxidil topical solution product labeling.
- U.S. Food and Drug Administration. Compounding and the FD&C Act, Section 503A. FDA Human Drug Compounding.